The following article features coverage from the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNSF) Annual Meeting. Click here to read more of MPR‘s conference coverage.
The Neosinus Health Nasal RinseTM (NeoSinus Health) device was associated with improved compliance and symptom scores in patients with allergic rhinitis, according to findings presented at the AAO-HNSF 2021 Annual Meeting.
The study authors conducted a single-center, randomized, single-blinded prospective cohort study where 52 adult patients were randomly assigned to perform daily nasal saline irrigation with either Neosinus Health Nasal Rinseor NeilMed Sinus RinseTM (NeilMed Pharmaceuticals). Both cohorts received the same oral antihistamine and intranasal corticosteroid spray.
“Subjective assessment was performed at baseline and at 4 weeks using the SNOT-20 questionnaire,” the authors reported. The study also evaluated compliance by correlating patient daily saline rinse responses to the number of unused salt packets.
Results showed that Neosinus Health Nasal Rinse was associated with statistically significantly greater improvement in SNOT-20 scores compared with the NeilMed Sinus Rinse (P <.01). Additionally, patients who received the novel device showed higher compliance rates vs those who received NeilMed Sinus Rinse (88% vs 61%; P <.05). Patients who used NeilMed Sinus Rinse noted drowning sensations and ear discomfort during rinsing as reasons for lower compliance; these side effects did not occur in the Neosinus group.
Based on these results, study authors concluded that the “Neosinus Health Nasal Rinse demonstrates significantly improved compliance rate and an average SNOT-20 score improvement compared with NeilMed Sinus Rinse” for patients with allergic rhinitis.
Mazhar K, Pugh M. Novel device improves compliance and SNOT-20 scores in allergic rhinitis. Presented at: AAO-HNSF 2021 Annual Meeting; October 3-6, 2021; Los Angeles, CA.